Fenster schließen  |  Fenster drucken

[posting]60008537[/posting]Ich habe noch ein Interview mit Todd Campbell vom Motley Fool gefunden, wo er sich auch dazu äußert:

https://finance.yahoo.com/news/4-disruptive-healthcare-stock…

Interessant daraus finde ich die Passage zur Historie:
One of the other things that attracted me to this company was the fact that this is a spinoff from Genomic Health . It got spun off in about 2012. Its cofounder and executive chairman is Randy Scott. Prior to founding Invitae, Randy was the cofounder of Genomic Health. He was also the founder of a company called Incyte . For listeners who may not be aware of it, Genomic Health has become one of the largest players in genetics. Their market cap is about $3 billion. Incyte has become a massive drug developer. Their market cap is about $17 billion. I like these been-there-done-that kind of leaders. With Randy Scott having been there and done that, that gives me a little additional confidence. He owns about 6.5% of Invitae shares.

bzw. zur Kooperation:
There's a lot to like about this company. I also like that they're not just focused on the consumer side, but also partnering with biopharmaceutical companies. They've got a partnership with Sarepta Therapeutics , a company we've talked about a lot on the show. They announced they were expanding that partnership in May or June of last year. You can see how they can grow the consumer side and also grow with the biopharmaceutical side, as well. A lot to like.

Ich will auch auf die anderen 3 Firmen einen Blick werfen. .. oder sind die Dir schon bekannt?
 
aus der Diskussion: Gewinnerbranchen der Jahre 2006 bis 2040
Autor (Datum des Eintrages): linkshaender  (03.03.19 14:30:15)
Beitrag: 85,082 von 94,068 (ID:60008624)
Alle Angaben ohne Gewähr © wallstreetONLINE